EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Neuroinflammatory Biomarkers in Alzheimer’s Disease: From Pathophysiology to Clinical Implications

Fausto Roveta iD, Lucrezia Bonino iD, Elisa Maria Piella, Innocenzo Rainero iD, Elisa Rubino

International Journal of Molecular Sciences · 06.11.2024 · 25 (22) · 11941

DOI: 10.3390/ijms252211941 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift International Journal of Molecular Sciences, online erschienen am 06.11.2024. Verfasst von Fausto Roveta und 4 weiteren Autor:innen. Beteiligte Einrichtung: Aging Brain and Memory Clinic, Department of Neuroscience "Rita Levi-Montalcini", University of Torino, 10126 Torino, Italy. Hauptthemen laut MEDLINE: Alzheimer Disease, Biomarkers, Neuroinflammatory Diseases. Die Arbeit wurde bisher 75-mal zitiert (Crossref) und nennt 133 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Associazione Italiana Ricerca Alzheimer Onlus, Dipartimenti di Eccellenza 2023-2027, Fondazione CRT.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The identification of neuroinflammation as a critical factor in Alzheimer’s disease (AD) has expanded the focus of research beyond amyloid-β and tau pathology. The neuroinflammatory fluid biomarkers GFAP, sTREM2, and YKL-40 have gained attention for their potential in early detection and monitoring of disease progression. Plasma GFAP has demonstrated promise in predicting the conversion from mild cognitive impairment to AD dementia, while sTREM2 highlights microglial activation, although there are conflicting results regarding its dynamics in AD pathogenesis. Advanced imaging techniques, such as PET tracers targeting TSPO and MAO-B, have also been developed to visualize glial activation in vivo, offering spatial and temporal insights into neuroinflammatory processes. However, the clinical implementation of these biomarkers faces challenges due to their lack of specificity, as many of them can be elevated in other conditions. Therapeutic strategies targeting neuroinflammation are emerging, with TREM2-targeting therapies and antidiabetic drugs like GLP-1 receptor agonists showing potential in modulating microglial activity. Nevertheless, the complexity of neuroinflammation, which encompasses both protective and harmful responses, necessitates further research to fully unravel its role and optimize therapeutic approaches for AD.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Alzheimer DiseaseBiomarkersNeuroinflammatory DiseasesHumansReceptors, ImmunologicMembrane GlycoproteinsAnimalsMicrogliaChitinase-3-Like Protein 1Glial Fibrillary Acidic ProteinCognitive Dysfunction

Stichwörter der Autor:innen

Alzheimer’s diseasebiomarkersneurobiological diseasesneuroinflammationneuropathogenesis

Substanzen

BiomarkersTREM2 protein, humanReceptors, ImmunologicMembrane GlycoproteinsChitinase-3-Like Protein 1Glial Fibrillary Acidic ProteinCHI3L1 protein, human

Autor:innen und Institutionen

  • Aging Brain and Memory Clinic, Department of Neuroscience "Rita Levi-Montalcini", University of Torino, 10126 Torino, Italy.

ORCID-Profile: Fausto Roveta, Lucrezia Bonino, Innocenzo Rainero

Förderung

  • Associazione Italiana Ricerca Alzheimer Onlus
  • Dipartimenti di Eccellenza 2023-2027
  • Fondazione CRT
  • Italian Ministry of University and Research (MUR)
  • Department of Neuroscience “Rita Levi-Montalcini”, University of Torino, Italy

Zitieren

APA

Roveta, F., Bonino, L., Piella, E. M., Rainero, I., & Rubino, E. (2024). Neuroinflammatory Biomarkers in Alzheimer’s Disease: From Pathophysiology to Clinical Implications. International Journal of Molecular Sciences, 25(22), 11941. https://doi.org/10.3390/ijms252211941

Vancouver

Roveta F, Bonino L, Piella EM, Rainero I, Rubino E. Neuroinflammatory Biomarkers in Alzheimer’s Disease: From Pathophysiology to Clinical Implications. International Journal of Molecular Sciences. 2024;25(22):11941. doi:10.3390/ijms252211941

BibTeX
@article{Roveta2024,
  author = {Roveta, Fausto and Bonino, Lucrezia and Piella, Elisa Maria and Rainero, Innocenzo and Rubino, Elisa},
  title = {Neuroinflammatory Biomarkers in Alzheimer’s Disease: From Pathophysiology to Clinical Implications},
  journal = {International Journal of Molecular Sciences},
  year = {2024},
  volume = {25},
  number = {22},
  pages = {11941},
  doi = {10.3390/ijms252211941}
}
Kostenlos starten →